These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
134 related items for PubMed ID: 1646485
21. Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study. Chalasani N, Baluyut A, Ismail A, Zaman A, Sood G, Ghalib R, McCashland TM, Reddy KR, Zervos X, Anbari MA, Hoen H. Hepatology; 2000 Jan; 31(1):7-11. PubMed ID: 10613720 [Abstract] [Full Text] [Related]
22. Early detection and treatment of cholangiocarcinoma. Gores GJ. Liver Transpl; 2000 Nov; 6(6 Suppl 2):S30-4. PubMed ID: 11084082 [Abstract] [Full Text] [Related]
23. Chromosome 9p21 loss and p16 inactivation in primary sclerosing cholangitis-associated cholangiocarcinoma. Ahrendt SA, Eisenberger CF, Yip L, Rashid A, Chow JT, Pitt HA, Sidransky D. J Surg Res; 1999 Jun 01; 84(1):88-93. PubMed ID: 10334895 [Abstract] [Full Text] [Related]
25. Outcome and prognostic factors of 391 Japanese patients with primary sclerosing cholangitis. Tanaka A, Takamori Y, Toda G, Ohnishi S, Takikawa H. Liver Int; 2008 Aug 01; 28(7):983-9. PubMed ID: 18397233 [Abstract] [Full Text] [Related]
26. Advanced cholangiocarcinoma in a patient with stage I primary sclerosing cholangitis. Ueda M, Nakamura T, Tohyama T, Kushihata F, Honda Y, Kobayashi N. J Hepatobiliary Pancreat Surg; 2003 Aug 01; 10(3):245-9. PubMed ID: 14605983 [Abstract] [Full Text] [Related]
27. Detection of cholangiocarcinoma with magnetic resonance spectroscopy of bile in patients with and without primary sclerosing cholangitis. Albiin N, Smith IC, Arnelo U, Lindberg B, Bergquist A, Dolenko B, Bryksina N, Bezabeh T. Acta Radiol; 2008 Oct 01; 49(8):855-62. PubMed ID: 18608012 [Abstract] [Full Text] [Related]
28. Dynamic FDG-PET is useful for detection of cholangiocarcinoma in patients with PSC listed for liver transplantation. Prytz H, Keiding S, Björnsson E, Broomé U, Almer S, Castedal M, Munk OL, Swedish Internal Medicine Liver Club. Hepatology; 2006 Dec 01; 44(6):1572-80. PubMed ID: 17133469 [Abstract] [Full Text] [Related]
30. Changes over a 20-year period in the clinical presentation of primary sclerosing cholangitis in Sweden. Bergquist A, Said K, Broomé U. Scand J Gastroenterol; 2007 Jan 01; 42(1):88-93. PubMed ID: 17190768 [Abstract] [Full Text] [Related]
31. Utility of bile duct brushings for the early detection of cholangiocarcinoma in patients with primary sclerosing cholangitis. Moff SL, Clark DP, Maitra A, Pandey A, Thuluvath PJ. J Clin Gastroenterol; 2006 Apr 01; 40(4):336-41. PubMed ID: 16633106 [Abstract] [Full Text] [Related]
33. Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis. Tischendorf JJ, Krüger M, Trautwein C, Duckstein N, Schneider A, Manns MP, Meier PN. Endoscopy; 2006 Jul 01; 38(7):665-9. PubMed ID: 16673310 [Abstract] [Full Text] [Related]
34. Cholangiocarcinoma in sclerosing cholangitis. The role of liver transplantation. Stieber AC, Marino IR, Iwatsuki S, Starzl TE. Int Surg; 1989 Jul 01; 74(1):1-3. PubMed ID: 2540107 [Abstract] [Full Text] [Related]
37. Prevention of bile duct cancer in primary sclerosing cholangitis. Harrison PM. Ann Oncol; 1999 Jul 01; 10 Suppl 4():208-11. PubMed ID: 10436824 [Abstract] [Full Text] [Related]
38. Primary sclerosing cholangitis: clinical presentation, natural history and prognostic variables: an Italian multicentre study. The Italian PSC Study Group. Okolicsanyi L, Fabris L, Viaggi S, Carulli N, Podda M, Ricci G. Eur J Gastroenterol Hepatol; 1996 Jul 01; 8(7):685-91. PubMed ID: 8853259 [Abstract] [Full Text] [Related]